FDA grants first full approval for an Alzheimer’s drug in 20 years
The agency previously granted Leqembi, developed and manufactured by Eisai and Biogen, accelerated approval before evaluating late-stage clinical trial data earlier this year. The drug moderately slowed trial participants’ cognitive …